Immunosuppressants/plasma/unspecified calcineurin inhibitors

Various toxicities: 3 case reports

    This is a preview of subscription content, log in to check access.

    Notes

    1. 1.

      Identifying patient details (age and sex) have been obtained through direct communication with the author.

    Reference

    1. Abe Y, et al. Successful treatment of anti-MDA5 antibody-positive refractory interstitial lung disease with plasma exchange therapy. Rheumatology 59: 767-771, No. 4, Apr 2020. Available from: URL: http://doi.org/10.1093/rheumatology/kez357

      Article  Google Scholar 

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Immunosuppressants/plasma/unspecified calcineurin inhibitors. Reactions Weekly 1806, 163 (2020). https://doi.org/10.1007/s40278-020-79181-1

    Download citation